jeudi 18 octobre 2012

Focus: A systematic review of symptom assessment scales in children with cancer




Abstract
BACKGROUND: The objective was to describe symptom assessment scales that have been used in children with cancer.
METHODS:
We conducted electronic searches of OVID Medline and EMBASE in order to identify all symptom assessment scales that have been used in pediatric cancer. Two reviewers abstracted information from each identified study. Data collected included study demographics and information related to the instrument and children enrolled. We also collected information about the purpose of instrument administration and whether treatment was altered as a result of this information.
RESULTS:
Fourteen studies were identified which evaluated eight different symptom assessment scales. Eight studies used child self-report and all studies included children on active treatment for cancer although 4 studies also included children following completion of treatment. The most common purpose of instrument administration was to measure the prevalence of symptom burden (n = 8). None of the 14 studies used the scale to screen for symptoms and none changed patient management on the basis of identified symptoms.
CONCLUSIONS:
We failed to identify any symptom assessment scales that were used as a symptom screening tool. There is a need to develop such a tool for use in children with cancer.

Source: A systematic review of symptom assessment scales in children with cancer. Dupuis LL, Tomlinson D, Ethier MC, Hesser T, Sung L (lillian.sung@sickkids.ca). BMC Cancer. 2012 Sep 26;12(1):430.
Free paper available at:

2 commentaires:

  1. Ce commentaire a été supprimé par l'auteur.

    RépondreSupprimer
  2. Cancer is one of the deadly disease which can affect everyone (children, men and women) irrespective of there age. Cancer is caused by uncontrollable cell growth in body which leads to formation of tumor. Cancer detected in earlier stages can be cured. Treatment of cancer can be surgery, chemotherapy, radiotherapy or immunotherapy.

    RépondreSupprimer